Stockscreener 앱 받기
0.2536
0.16%
0.0004
시간 외 거래:
.25
-0.0036
-1.42%
전일 마감가:
$0.2532
열려 있는:
$0.2548
하루 거래량:
2.49M
Relative Volume:
0.27
시가총액:
$25.52M
수익:
$69.49M
순이익/손실:
$-21.13M
주가수익비율:
-0.3908
EPS:
-0.649
순현금흐름:
$-14.46M
1주 성능:
-7.17%
1개월 성능:
+15.38%
6개월 성능:
-30.71%
1년 성능:
-69.81%
1일 변동 폭
$0.2452
$0.2731
1주일 범위
$0.2452
$0.2799
52주 변동 폭
$0.1616
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.2536 | 25.52M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
881.51 | 102.78B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
321.57 | 61.36B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
234.57 | 54.56B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
88.36 | 9.85B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.8392 | 718.95M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health reports record revenue, retires $8M debt early By Investing.com - Investing.com Australia
Cosmos Health: A Company Transformed — 2026 Y - Moomoo
Cosmos Health Reaffirms 2029 Guidance - TradingView
Cosmos Health Q2FY26 Results: Revenue up 28.8% to $18.99M - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure, Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions - marketscreener.com
Cosmos Health stock rises after $8 million note retirement - AD HOC NEWS
Cosmos Health retires $8M convertible note early By Investing.com - Investing.com UK
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions - kommunikasjon.ntb.no
COSMOS HEALTH INC: OPERATING CASH REQUIREMENTS REDUCED BY MORE THAN 30% - Moomoo
Cosmos Health projects $6M revenue from Oliv18 supplement launch - Investing.com India
COSM Looks 33.4% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Cosmos Health projects $6M revenue from Oliv18 supplement launch By Investing.com - Investing.com Nigeria
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories - Barchart.com
Weekly Recap: Cosmos Health Q2 revenue gains and five‑year Innova Saudi deal - TradingView
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
Is Cosmos Health Inc (COSM) Undervalued After Q2 Earnings Miss? GF Score: 29/100, Revenue at $18.99 Million - GuruFocus
Cosmos Reports Record Q2: Revenue $19.0M, H1 $36.9M; Adjusted Gross Profit Up 58% - TradingView
Cosmos Health Company Profile & Introduction - Moomoo
COSM Looks 40.0% Undervalued on GF Value™ Amid Distribution Deal - GuruFocus
Cosmos Health signs exclusive Saudi distribution deal for supplements By Investing.com - Investing.com South Africa
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare - TradingView
Cosmos Health signs exclusive Saudi distribution deal for supplements - Investing.com
Cosmos Health Secures Exclusive Saudi Arabia Distribution Agreement for Sky Premium Life with Innova Healthcare - Quiver Quantitative
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term - Yahoo Finance
COSM Looks 43.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
MSN Money - MSN
Cosmos (COSM) Latest Quarter: The EPS Result Is Below Expectation in the Reported Period; Closing Reaction: The Stock Loses 6.20% in the Current UpdateAdjusted Earnings Analysis - Vinanet
Cosmos Health reports record Q2 revenue of $19 million By Investing.com - Investing.com Nigeria
Cosmos Health reports record Q2 revenue of $19 million, up 29% - Investing.com Nigeria
Cosmos Health Q2 Results: EPS Misses Estimate, Sales Rise 29% YoY - scanx.trade
Cosmos Health Reports Q2 2026 - TradingView
Cosmos Health Reports Record Q2 and First-Half 2026 Revenue, Exceeds $75 Million Adjusted Annualized Run-Rate - Quiver Quantitative
BRIEF-Cosmos Health Q2 Gross Profit USD 1.51 Million - TradingView
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway - marketscreener.com
Press Release: Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Progra - Moomoo
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health reports record Q2 revenue of $19 million - Investing.com
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cosmos Health Inc 주식 (COSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
4.05%
1.44%
자본화:
|
볼륨(24시간):